Cargando…
Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis
BACKGROUND: Both catheter and surgical ablation strategies offer effective treatments of atrial fibrillation (AF). The hybrid (joint surgical and catheter) ablation for AF is an emerging rhythm control strategy. We sought to determine the efficacy and safety of hybrid ablation of AF. METHODS: System...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390199/ https://www.ncbi.nlm.nih.gov/pubmed/36003726 http://dx.doi.org/10.1016/j.xjon.2021.07.005 |
_version_ | 1784770600327184384 |
---|---|
author | Varzaly, Jason A. Lau, Dennis H. Chapman, Darius Edwards, James Worthington, Michael Sanders, Prashanthan |
author_facet | Varzaly, Jason A. Lau, Dennis H. Chapman, Darius Edwards, James Worthington, Michael Sanders, Prashanthan |
author_sort | Varzaly, Jason A. |
collection | PubMed |
description | BACKGROUND: Both catheter and surgical ablation strategies offer effective treatments of atrial fibrillation (AF). The hybrid (joint surgical and catheter) ablation for AF is an emerging rhythm control strategy. We sought to determine the efficacy and safety of hybrid ablation of AF. METHODS: Systematic review and meta-analysis interrogating PubMed, EMBASE, and Cochrane databases from January 1, 1991, to November 30, 2017, using the following search terms: “Cox-maze,” “mini-maze,” “ablation methods (including radiofrequency, cryoablation, cryomaze),” and “surgery.” Included studies required ablation procedures to be hybrid and report rhythm follow-up. RESULTS: We included 925 patients with AF (38% persistent, 51% longstanding persistent) from 22 single-center studies (mean follow-up of 19 months). The surgical lesion set consisted of pulmonary vein isolation (n = 11) or box lesion (n = 11) with variable additional linear ablation. This was followed by sequential (n = 9), staged (n = 9), or combination (n = 4) catheter-based ablation to ensure isolation of pulmonary veins and to facilitate additional ablation or consolidation of surgically ablated lines. Overall, sinus rhythm maintenance was 79.4% (95% confidence interval [CI], 72.4-85.7] and 70.7% (95% CI, 62.2-78.7) with and without antiarrhythmic drugs, respectively at 19 ± 25 (range, 6-128) months. The use of the bipolar AtriCure Synergy system and left atrial appendage exclusion conferred superior rhythm outcome without antiarrhythmic drugs (P ≤ .01). The overall complication rate was 6.5% (95% CI, 3.4-10.2): mortality 0.2% (95% CI, 0-0.9); stroke 0.3% (95% CI, 0-1.1); reoperation for bleeding 1.6% (95% CI, 0.6-3.0); permanent pacing ~0% (95% CI, 0-0.5); conversion to sternotomy 0.3% (95% CI, 0-1.1); atrioesophageal fistula ~0% (95% CI, 0-0.5); and phrenic nerve injury 0.3% (95% CI, 0-1.1). CONCLUSIONS: Hybrid ablation therapy for AF demonstrates favorable rhythm outcome with acceptable complication rates. |
format | Online Article Text |
id | pubmed-9390199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-93901992022-08-23 Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis Varzaly, Jason A. Lau, Dennis H. Chapman, Darius Edwards, James Worthington, Michael Sanders, Prashanthan JTCVS Open Adult: Arrhythmias BACKGROUND: Both catheter and surgical ablation strategies offer effective treatments of atrial fibrillation (AF). The hybrid (joint surgical and catheter) ablation for AF is an emerging rhythm control strategy. We sought to determine the efficacy and safety of hybrid ablation of AF. METHODS: Systematic review and meta-analysis interrogating PubMed, EMBASE, and Cochrane databases from January 1, 1991, to November 30, 2017, using the following search terms: “Cox-maze,” “mini-maze,” “ablation methods (including radiofrequency, cryoablation, cryomaze),” and “surgery.” Included studies required ablation procedures to be hybrid and report rhythm follow-up. RESULTS: We included 925 patients with AF (38% persistent, 51% longstanding persistent) from 22 single-center studies (mean follow-up of 19 months). The surgical lesion set consisted of pulmonary vein isolation (n = 11) or box lesion (n = 11) with variable additional linear ablation. This was followed by sequential (n = 9), staged (n = 9), or combination (n = 4) catheter-based ablation to ensure isolation of pulmonary veins and to facilitate additional ablation or consolidation of surgically ablated lines. Overall, sinus rhythm maintenance was 79.4% (95% confidence interval [CI], 72.4-85.7] and 70.7% (95% CI, 62.2-78.7) with and without antiarrhythmic drugs, respectively at 19 ± 25 (range, 6-128) months. The use of the bipolar AtriCure Synergy system and left atrial appendage exclusion conferred superior rhythm outcome without antiarrhythmic drugs (P ≤ .01). The overall complication rate was 6.5% (95% CI, 3.4-10.2): mortality 0.2% (95% CI, 0-0.9); stroke 0.3% (95% CI, 0-1.1); reoperation for bleeding 1.6% (95% CI, 0.6-3.0); permanent pacing ~0% (95% CI, 0-0.5); conversion to sternotomy 0.3% (95% CI, 0-1.1); atrioesophageal fistula ~0% (95% CI, 0-0.5); and phrenic nerve injury 0.3% (95% CI, 0-1.1). CONCLUSIONS: Hybrid ablation therapy for AF demonstrates favorable rhythm outcome with acceptable complication rates. Elsevier 2021-07-16 /pmc/articles/PMC9390199/ /pubmed/36003726 http://dx.doi.org/10.1016/j.xjon.2021.07.005 Text en Crown Copyright © 2021 Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Adult: Arrhythmias Varzaly, Jason A. Lau, Dennis H. Chapman, Darius Edwards, James Worthington, Michael Sanders, Prashanthan Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title | Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title_full | Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title_fullStr | Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title_full_unstemmed | Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title_short | Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis |
title_sort | hybrid ablation for atrial fibrillation: a systematic review and meta-analysis |
topic | Adult: Arrhythmias |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390199/ https://www.ncbi.nlm.nih.gov/pubmed/36003726 http://dx.doi.org/10.1016/j.xjon.2021.07.005 |
work_keys_str_mv | AT varzalyjasona hybridablationforatrialfibrillationasystematicreviewandmetaanalysis AT laudennish hybridablationforatrialfibrillationasystematicreviewandmetaanalysis AT chapmandarius hybridablationforatrialfibrillationasystematicreviewandmetaanalysis AT edwardsjames hybridablationforatrialfibrillationasystematicreviewandmetaanalysis AT worthingtonmichael hybridablationforatrialfibrillationasystematicreviewandmetaanalysis AT sandersprashanthan hybridablationforatrialfibrillationasystematicreviewandmetaanalysis |